The list of 36 drugs, which are exempt from basic customs duty, includes many expensive and imported medicines that can ...

Takeda’s agreement with Evox covers a ... Vertex's gene-editing therapy for sickle cell disease, Casgevy, has been given the nod for use by the NHS in England after an earlier rejection.

Notable performers include Zytiga (prostate cancer), Imbruvica (chronic lymphocytic leukaemia and mantle cell lymphoma (co ... company on the rise is Takeda. The Japanese company rose 14 places ...

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its ...

A discovery about the mechanisms that enable the immune system to sustain long-term protection could revolutionize treatment for chronic disease and cancer.

Organ Transplantation Immunosuppressive Drug Market. Global Organ Transplantation Immunosuppressive Drug market presents significant growth opportunities.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...